MEDICAMENTOS EXCLUSIVOS: ERLOTINIB (TARCEVA), PERTUZUMAB (PERJETA), TRASTUZUMAB EMTANSINA (KADCYLA), RITUXIMAB SC (MABTHERA SC), OBINUTUZUMAB (GAZYVARO), VISMODEGIB (ERIVEDGE).
Tender information
TED EUMadrid, Spain
- Type
- 29
- Procedure
- neg-wo-call
- Ref. number
- 226013-2024
- Estimated value
- 167,059 EUR
- CPV
- 33600000
MEDICAMENTOS EXCLUSIVOS: ERLOTINIB (TARCEVA), PERTUZUMAB (PERJETA), TRASTUZUMAB EMTANSINA (KADCYLA), RITUXIMAB SC (MABTHERA SC), OBINUTUZUMAB (GAZYVARO), VISMODEGIB (ERIVEDGE).